MiSight packshot Banner overlay

CooperVision to donate $500k to children’s vision campaign

The contact lens company is on track to make its donation target by 2020

30 Jul 2019 by Emily McCormick

Contact lens manufacturer CooperVision has confirmed that it is on track to donate $500,000 (£409,000) to a campaign that aims to reach 50 million children by the end of 2020.

The donation will be made to Our Children’s Vision and is generated from sales of the company’s MiSight contact lens.

CooperVision has been supporting the Our Children’s Vision campaign by donating a percentage of sales from its MiSight one day contact lens for the last two years. Its latest pledge sees the donation of sales extended to all MiSight lenses.

CEO of the Brien Holden Vision Institute which founded the campaign, Yvette Waddell, said: “We firmly believe having strong partnerships in place can get us further than any individual effort. The assistance we’re receiving from CooperVision will help us reach more children and provide greater access to eye health services in underserved communities, as well as help advocate on behalf of a vulnerable demographic to ensure child eye health is integrated into country and education policies.”

The Our Children’s Vision initiative is a global network of partners that are working with individuals, governments, department agencies and the public to provide eye care and spectacles to children.

Statistics published in Ophthalmology in 2016 estimate that myopia will affect almost five billion people globally by 2050.

Speaking about the pledge, president of CooperVision’s speciality eyecare division, Dr Juan Carlos Aragon, said: “Myopia progression and it’s increasing prevalence is an epidemic that will threaten economic productivity and have social implications. That is why we are working diligently on the best ways to help manage the progression of the condition in children to help them see clearly, minimise the risk of potential ocular disease related to high levels of myopia and live brightly.”

Advertisement

Your comments

You must be logged in to join the discussion. Log in

Comments (0)

Report a comment
Close modal